A Study of LY2157299 Monohydrate in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This study involves a single dose of 150 milligram (mg) of radiolabeled LY2157299 monohydrate in healthy participants. The study will determine how the body eliminates the radioactivity and LY2157299 monohydrate. Participants must be healthy surgically sterile or postmenopausal females, or sterile males. This study is approximately 8 to 15 days.

Key facts

Study ID

NCT01746004

Run by

Eli Lilly and Company

People needed

8

Starts

2013-01-01

Expected to finish

2013-02-01

Last updated by the study team

2013-02-15

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy surgically sterile females, postmenopausal females, or sterile males
• Body mass index (BMI) of 18.5 to 32.0 kilograms per square meter (kg/m\^2)
• Have venous access sufficient to allow for blood sampling

You may not qualify if…

• Have known allergies to LY2157299, related compounds or any components of the formulation
• Have an abnormal blood pressure as determined by the investigator
• Have participated in a [\^14C]-study within the last 6 months prior to admission for this study

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.